Abstract
A plethora of regulations require that many chemicals and chemical products are tested for efficacy and/or toxicity. When permitted to operate effectively and without bias, the ECVAM/ICCVAM/OECD validation process can be used to independently establish that new animal and non-animal test procedures are sufficiently relevant and reliable for their stated purposes and should be considered for regulatory use. However, the validation process is under threat because of vested interests of various kinds, and it is clear that many currently-accepted animal tests and candidate animal and non-animal tests do not, and could never, meet the agreed criteria for necessity, test development, prevalidation, validation and acceptance. We therefore need an invalidation process to parallel and protect the validation process, so that such methods could be independently reviewed and declared irrelevant and/or unreliable for their claimed purposes. An additional advantage of such a process would be that valuable resources would no longer be wasted in attempts to secure the acceptance of inherently inadequate tests.
Subject
Medical Laboratory Technology,Toxicology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Alternative Toxicity Test Methods;The History of Alternative Test Methods in Toxicology;2019
2. The Validation of Alternative Test Methods;The History of Alternative Test Methods in Toxicology;2019
3. The Replacement of Animal Tests;Alternatives to Laboratory Animals;2018-05
4. The European Citizens’ Stop Vivisection Initiative and the Revision of Directive 2010/63/EU;Alternatives to Laboratory Animals;2016-09
5. Toxicokinetic studies in vitro;Principles of Toxicology Testing;2013-04-02